Skip to main content
Clinical Trials/ISRCTN96891086
ISRCTN96891086CompletedNot Applicable

Artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated malaria treatment in children with or without sickle cell disease: a randomized efficacy and safety trial

Danida Fellowship Centre (Denmark)0 sites120 target enrollmentStarted: October 2, 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Children with SCD
  • 2. Aged 6 months to 12 years
  • 3. With acute P. falciparum malaria of parasite density < 200,000/µl
  • 4. Consent obtained and willingness by parent or guardian to comply with the follow-up schedule

Exclusion Criteria

  • 1. Symptoms or signs of severe malaria requiring parenteral treatment
  • 2. Weight less than 5 kg
  • 3. Presence of danger signs of malaria
  • 4. Known intolerance or allergy to study medications
  • 5. Reported treatment with any of the study drugs one month preceding enrolment
  • 6. Blood transfusion preceding 3 months before enrolment

Investigators

Sponsor
Danida Fellowship Centre (Denmark)

Similar Trials